PDLIM7 and neoplasm: LMP1‐specific CAR‐T cells have been developed and have demonstrated effective cytotoxicity against LMP1‐positive target cells in vitro, as well as inhibition of LMP1‐expressing NPC tumour growth in subcutaneous xenograft mouse models [75].